<DOC>
	<DOCNO>NCT00003447</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Randomized phase III trial compare effectiveness vinorelbine , gemcitabine , treat patient stage IIIB stage IV non-small cell lung cancer .</brief_summary>
	<brief_title>Vinorelbine and/or Gemcitabine Treating Older Patients With Stage IIIB Stage IV Non-small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine activity toxicity gemcitabine elderly patient non-small cell lung cancer . II . Determine activity toxicity combination gemcitabine vinorelbine patient . III . Compare survival rate quality life patient treat combination chemotherapy versus single agent chemotherapy . IV . Compare objective response time progression patient treat chemotherapy regimen . V. Compare toxicity three regimen patient . VI . Compare number hospitalization , palliative radiation therapy , antibiotic therapy , corticosteroid therapy , analgesic therapy , hematopoietic growth factor therapy need patient treated chemotherapy regimen . OUTLINE : This randomize , multicenter study . Patients stratify center , stage disease ( IIIB v IV ) , performance status ( 0 vs 1 v 2 ) . Patients randomize one three treatment arm . Patients receive either vinorelbine IV , gemcitabine IV , day 1 8 21 day course . Patients achieve objective response stable disease 3 course receive 3 course ( total 6 course ) . Quality life assess treatment , course 4 ( 3 week course 3 , therapy stop ) , 21 day course 6 ( 12 week course 3 ) . PROJECTED ACCRUAL : A total 630 patient ( 210 patient per arm ) accrue study .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Vinorelbine</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically proven nonsmall cell lung cancer Stage IV OR Stage IIIB supraclavicular lymph node metastases pleural deposit curable surgery radical radiotherapy No brain metastasis suspect clinically demonstrate radiologically PATIENT CHARACTERISTICS : Age : 70 Performance status : ECOG 02 Life expectancy : Not specify Hematopoietic : Neutrophil count least 2000/mm3 Platelet count least 100,000/mm3 Hemoglobin least 10 g/dL Hepatic : ( Unless cause tumor ) Bilirubin great 1.25 time upper limit normal ( ULN ) SGOT SGPT great 1.25 time ULN Renal : Creatinine great 1.5 mg/dL Other : No serious medical illness No prior concurrent malignancy except curatively treat basal cell squamous cell skin cancer carcinoma situ cervix PRIOR CONCURRENT THERAPY : No prior chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
</DOC>